Latest / Durham News Today | 2 Min News | The Daily News Now!
Lilly’s Global Obesity Surge | Durham News
Eli Lilly’s Q2 earnings shattered expectations and shifted investor focus from U.S. launch concerns to explosive international growth, especially in Europe, Japan, and China, where their GLP-1 drugs and upcoming oral pill Foundayo are poised to dominate. Bank of America raised its price target, citing faster-than-competitor growth and a massive 50% revenue surge, while Lilly confidently boosted its full-year forecast. With a deep R&D pipeline and global approvals already in place, the company is betting big on overseas markets to outpace domestic sales — and analysts are cheering them on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.